Get the Stockscreener App
1.95
1.56%
0.03
Inmune Bio Inc stock is traded at $1.95, with a volume of 795.58K.
It is up +1.56% in the last 24 hours and down -27.51% over the past month.
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.
See More
Previous Close:
$1.92
Open:
$1.92
24h Volume:
795.58K
Relative Volume:
0.25
Market Cap:
$51.84M
Revenue:
$155.00K
Net Income/Loss:
$-30.01M
P/E Ratio:
-1.1677
EPS:
-1.67
Net Cash Flow:
$-11.98M
1W Performance:
-3.94%
1M Performance:
-27.51%
6M Performance:
-76.16%
1Y Performance:
-67.50%
1-Day Range:
$1.855
$2.00
1-Week Range:
$1.855
$2.08
52-Week Range:
$1.855
$11.64
Inmune Bio Inc Stock (INMB) Company Profile
Name
Inmune Bio Inc
Sector
Industry
Phone
(858) 964-3720
Address
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, CA
Compare INMB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INMB
Inmune Bio Inc
|
1.95 | 51.04M | 155.00K | -30.01M | -11.98M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Inmune Bio Inc Stock (INMB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-01-25 | Downgrade | BTIG Research | Buy → Neutral |
| Jul-01-25 | Downgrade | Scotiabank | Sector Outperform → Sector Underperform |
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Oct-21-24 | Initiated | Alliance Global Partners | Buy |
| Sep-27-24 | Initiated | Raymond James | Outperform |
| Aug-22-24 | Initiated | Scotiabank | Sector Outperform |
| Jun-01-23 | Initiated | Robert W. Baird | Outperform |
| May-24-22 | Downgrade | B. Riley Securities | Buy → Neutral |
| Jul-07-21 | Reiterated | Maxim Group | Buy |
| Apr-21-21 | Initiated | B. Riley Securities | Buy |
| Jan-22-21 | Reiterated | Maxim Group | Buy |
| Sep-01-20 | Initiated | BTIG Research | Buy |
| Jul-15-20 | Reiterated | H.C. Wainwright | Buy |
View All
Inmune Bio Inc Stock (INMB) Latest News
INmune Bio Inc. stock trend forecastJuly 2025 Fed Impact & Long-Term Safe Investment Ideas - Newser
Technical signs of recovery in INmune Bio Inc.Quarterly Profit Summary & High Accuracy Investment Entry Signals - Newser
What is INmune Bio Inc.’s book value per shareJuly 2025 Drop Watch & AI Based Trade Execution Alerts - خودرو بانک
Is INmune Bio Inc. stock a falling knife or bargain buyJuly 2025 Closing Moves & Verified Short-Term Plans - خودرو بانک
Relative strength of INmune Bio Inc. in sector analysisTrade Risk Summary & Daily Technical Forecast Reports - Newser
Is INmune Bio Inc. stock a value trap2025 Pullback Review & Weekly Watchlist of Top Performers - خودرو بانک
What momentum shifts mean for INmune Bio Inc.Quarterly Growth Report & Low Drawdown Trading Strategies - Newser
Technical signs of recovery in INmune Bio Inc2025 Price Action Summary & Momentum Based Trading Ideas - Newser
What’s next for INmune Bio Inc. stock priceJuly 2025 Outlook & Real-Time Stock Price Movement Reports - Newser
Detecting price anomalies in INmune Bio Inc. with AIExit Point & Risk Controlled Swing Alerts - Newser
Can INmune Bio Inc. rally from current levelsPortfolio Growth Summary & Consistent Profit Focused Trading Strategies - Newser
What makes INmune Bio Inc. stock price move sharplyJuly 2025 Snapshot & Stock Portfolio Risk Control - Newser
What to do if you’re stuck in INmune Bio Inc.Stock Surge & Free High Accuracy Swing Entry Alerts - Newser
News impact scoring models applied to INmune Bio Inc.Weekly Trading Summary & Daily Growth Stock Investment Tips - Newser
Will INmune Bio Inc. outperform the market in YEARTrade Exit Report & Daily Technical Stock Forecast Reports - خودرو بانک
Evaluating INmune Bio Inc. with trendline analysisQuarterly Portfolio Report & Stepwise Trade Signal Implementation - Newser
Can swing trading help recover from INmune Bio Inc. lossesJuly 2025 Short Interest & Capital Efficiency Focused Strategies - Newser
INmune Bio Inc.’s volatility index tracking explainedGold Moves & Verified Momentum Stock Alerts - Newser
Inmune Bio Inc. shares rise 1.02% premarket after Tevogen Bio Holdings Inc. highlights the importance of SARS-CoV-2 treatments for weakened immune systems. - AInvest
Visual analytics tools that track INmune Bio Inc. performanceQuarterly Trade Review & Community Consensus Trade Alerts - Newser
Will INmune Bio Inc. be affected by tariffs2025 Trade Ideas & Entry Point Strategy Guides - خودرو بانک
Can you recover from losses in INmune Bio Inc.Treasury Yields & Advanced Swing Trade Entry Alerts - Newser
Will INmune Bio Inc. outperform tech stocksJuly 2025 Sector Moves & Stepwise Trade Signal Implementation - خودرو بانک
Backtesting results for INmune Bio Inc. trading strategiesJuly 2025 Drop Watch & Low Drawdown Trading Techniques - Newser
Is INmune Bio Inc. stock bottoming outOptions Play & Fast Gain Stock Trading Tips - Newser
Is INmune Bio Inc. forming a double bottomStock Surge & Weekly Return Optimization Plans - خودرو بانک
Real time social sentiment graph for INmune Bio Inc.July 2025 Sector Moves & Stepwise Trade Execution Plans - Newser
Is INmune Bio Inc. stock reversal real or fake2025 Market WrapUp & Community Trade Idea Sharing - Newser
Is INmune Bio Inc. still worth holding after the dipWeekly Trend Summary & Long Hold Capital Preservation Tips - Newser
Geopolitics Watch: Is INmune Bio Inc. showing insider buying2025 Macro Impact & Weekly Market Pulse Updates - خودرو بانک
What data driven models say about INmune Bio Inc.’s future2025 Pullback Review & AI Powered Market Trend Analysis - Newser
Can INmune Bio Inc. recover in the next quarterJuly 2025 Market Mood & Real-Time Buy Signal Notifications - Newser
Analyzing INmune Bio Inc. with multi timeframe chartsJuly 2025 Closing Moves & Stepwise Trade Execution Plans - Newser
Tools to monitor INmune Bio Inc. recovery probability2025 Market Outlook & AI Forecast Swing Trade Picks - Newser
Should I hold or sell INmune Bio Inc. now2025 Top Decliners & Stepwise Swing Trade Plans - خودرو بانک
Is INmune Bio Inc. impacted by rising ratesMarket Performance Report & High Conviction Buy Zone Alerts - خودرو بانک
Can INmune Bio Inc. hit a new high this month2025 Price Targets & Safe Entry Trade Signal Reports - Newser
Inmune Bio Inc Stock (INMB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):